APA (2000). Diagnostic and Statistical Manual of Mental Disorders, 4th edn, text revision (DSM-IV-TR). American Psychiatric Association: Washington, DC.
Barry ES, Naus MJ, Rehm LP (2004). Depression and implicit memory: understanding mood congruent memory bias. Cognitive Therapy and Research 28, 387–414.
Beck AT, Rush AJ, Shaw BF, Emery G (1979). Cognitive Therapy of Depression. Guilford Press: New York.
Beck AT, Ward CH, Mendelson M, Mock JE, Erbaugh JK (1961). An inventory for measuring depression. Archives of General Psychiatry 4, 561–571.
Bothwell S, Weissman MM (1977). Social impairments four years after an acute depressive episode. American Journal of Orthopsychiatry 47, 231–237.
Cassano P, Fava M (2002). Depression and public health: an overview. Journal of Psychosomatic Research 53, 849–857.
Crowe M, Luty S (2005). The process of change in Interpersonal Psychotherapy (IPT) for depression: a case study for the new IPT therapist. Psychiatry: Interpersonal and Biological Processes 68, 43–54.
De Lisio G, Maremmani I, Perugi G, Cassano GB, Deltito J, Akiskal HS (1986). Impairment of work and leisure in depressed outpatients. A preliminary communication. Journal of Affective Disorders 10, 79–84.
Dimidjian S, Hollon SD, Dobson KS, Schmaling KB, Kohlenberg RJ, Addis ME, Gallop R, McGlinchey JB, Markley DK, Gollan JK, Atkins DC, Dunner DL, Jacobson NS (2006). Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the acute treatment of adults with major depression. Journal of Consulting and Clinical Psychology 74, 658–670.
Dunn TW, Jarrett RB (2009). Psychosocial functioning. In The International Encyclopedia of Depression (ed. Ingram R.), pp. 468–471. Springer: New York, NY.
Elkin I, Shea TM, Watkins JT, Imber SD, Sotsky SM, Collins JF, Glass DR, Pilkonis PA, Leber WR, Docherty JP, Fiester SJ, Parloff MB (1989). National Institute of Mental Health Treatment of Depression Collaborative Research Program: general effectiveness of treatments. Archives of General Psychiatry 46, 802–-982.
Evans MD, Hollon SD, DeRubeis RJ, Piasecki JM, Grove WM, Garvey MJ, Tuason VB (1992). Differential relapse following cognitive therapy and pharmacotherapy for depression. Archives of General Psychiatry 49, 802–808.
Finkelstein SN, Berndt ER, Greenberg PE, Parsley RA, Russell JM, Keller MB (1996). Improvement in subjective work performance after treatment of chronic depression: some preliminary results. Psychopharmacology Bulletin 32, 33–40.
First MB, Spitzer RL, Gibbon M, Williams JB (1996). Structured Clinical Interview for DSM-IV Axis I Disorders – Patient Edition (SCID-I/P, Version 2.0). Biometrics Research Department, New York State Psychiatric Institute: New York, NY.
Follette WC, Greenberg LS (2005). Technique factors in treating dysphoric disorders. In Principles of Therapeutic Change that Work (ed. Castonguay L. G. and Beutler L. E.), pp. 83–110. Oxford University Press: New York.
Garratt G, Ingram RE, Rand KL, Sawalani G (2007). Cognitive processes in cognitive therapy: evaluation of the mechanisms of change in the treatment of depression. Clinical Psychology: Science and Practice 14, 224–239.
Gorenstein C, Andrade L, Moreno RA, Artes R (2002). Social adjustment in depressed patients treated with venlafaxine and amitriptyline. International Clinical Psychopharmacology 17, 171–175.
Greenberg PE, Kessler RC, Birnbaum HG, Leong SA, Lowe SW, Berglund PA, Corey-Lisle PK (2003). The economic burden of depression in the United States: how did it change between 1990 and 2000? Journal of Clinical Psychiatry 64, 1465–1475.
Hamilton M (1960). A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry 12, 52–62.
Hays RD, Wells KB, Sherbourne CD, Rogers W, Spritzer K (1995). Functioning and well-being outcomes of patients with depression compared with chronic general medical illnesses. Archives of General Psychiatry 52, 11–19.
Hirschfeld RM, Dunner DL, Keitner G, Klein DN, Koran LM, Kornstein SG, Markowitz JC, Miller I, Nemeroff CB, Ninan PT, Rush AJ, Schatzberg AF, Thase ME, Trivedi MH, Borian FE, Crits-Christoph P, Keller MB (2002). Does psychosocial functioning improve independent of depressive symptoms? A comparison of nefazodone, psychotherapy, and their combination. Biological Psychiatry 51, 123–133.
Hirschfeld RM, Russell JM, Delgado PL, Fawcett J, Friedman RA, Harrison WM, Koran LM, Miller IW, Thase ME, Howland RH, Connolly MA, Miceli RJ (1998). Predictors of response to acute treatment of chronic and double depression with sertraline or imipramine. Journal of Clinical Psychiatry 59, 669–675.
Hollon SD, DeRubeis RJ, Evans MD, Wiemer MJ, Garvey MJ, Grove WM, Tuason VB (1992). Cognitive therapy and pharmacotherapy for depression: singly and in combination. Archives of General Psychiatry 49, 774–781.
Hollon SD, DeRubeis RJ, Shelton RC, Amsterdam JD, Salomon RM, O'Reardon JP, Lovett ML, Young PR, Haman KL, Freeman BB, Gallop R (2005). Prevention of relapse following cognitive therapy vs. medications in moderate to severe depression. Archives of General Psychiatry 62, 417–422.
Jarrett RB, Thase ME (2010). Comparative efficacy and durability of continuation phase cognitive therapy for preventing recurrent depression: design of a double-blinded fluoxetine- and pill placebo-controlled randomized trial with 2-year follow-up. Contemporary Clinical Trials 31, 355–377.
Keller MB (2003). Past, present, and future directions for defining optimal treatment outcome in depression: remission and beyond. Journal of the American Medical Association 289, 3152–3160.
Keller MB, Lavori PW, Friedman B, Nielsen E, Endicott J, McDonald-Scott P, Andreasen NC (1987). The longitudinal interval follow-up evaluation: a comprehensive method for assessing outcome in prospective longitudinal studies. Archives of General Psychiatry 44, 540–548.
Kessler RC, Berglund P, Demler O, Jin R, Walters EE (2005). Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry 62, 593–602.
Kline RB (2005). Principles and Practice of Structural Equation Modeling. Guilford Press: New York.
Kraemer HC, Stice E, Kazdin A, Offord D, Kupfer D (2001). How do risk factors work together? Mediators, moderators, independent, overlapping, and proxy risk factors. American Journal of Psychiatry 158, 848–856.
Lenderking WR, Tennen H, Nackley JF, Hale MS, Turner RR, Testa MA (1999). The effects of venlafaxine on social activity level in depressed outpatients. Journal of Clinical Psychiatry 60, 157–163.
Leon AC, Solomon DA, Mueller TI, Turvey CL, Endicott J, Keller MB (1999). The Range of Impairment Functioning Tool (LIFE-RIFT): a brief measure of functional impairment. Psychological Medicine 29, 869–878.
Miller IW, Keitner GI, Schatzberg AF, Klein DN, Thase ME, Rush AJ, Markowitz JC, Schlager DS, Kornstein SG, Davis SM, Harrison WM, Keller MB (1998). The treatment of chronic depression, part 3: Psychosocial functioning before and after treatment with sertraline or imipramine. Journal of Clinical Psychiatry 59, 608–619.
Mintz J, Mintz LI, Arruda MJ, Hwang SS (1992). Treatments of depression and the functional capacity to work. Archives of General Psychiatry 49, 761–768.
Moos RH, Cronkite RC (1999). Symptom-based predictors of a 10-year chronic course of treated depression. Journal of Nervous and Mental Disease 187, 360–368.
Ro E, Clark LA (2009). Psychosocial functioning in the context of diagnosis: assessment and theoretical issues. Psychological Assessment 21, 313–324.
Rush AJ, Gullion CM, Basco MR, Jarrett RB, Trivedi MH (1996). The Inventory of Depressive Symptomatology (IDS): psychometric properties. Psychological Medicine 26, 477–486.
Rush AJ, Kraemer HC, Sackeim HA, Fava M, Trivedi MH, Frank E, Ninan PT, Thase ME, Gelenberg AJ, Kupfer DJ, Regier DA, Rosenbaum JF, Ray O, Schatzberg AF; ACNP Task Force (2006). Report by the ACNP task force on response and remission in major depressive disorder. Neuropsychopharmacology 31, 1841–1853.
Schafer J, Graham J (2002). Missing data: our view of the state of the art. Psychological Methods 7, 147–177.
Spanier GB (1976). Measuring dyadic adjustment: new scales for assessing the quality of marriage and similar dyads. Journal of Marriage and the Family 38, 15–28.
Thase ME (2003). Evaluating antidepressant therapies: remission as the optimal outcome. Journal of Clinical Psychiatry 64 (Suppl. 13), 18–25.
Vittengl JR, Clark LA, Jarrett RB (2004). Improvement in social-interpersonal functioning after cognitive therapy for recurrent depression. Psychological Medicine 34, 643–658.
Vittengl JR, Clark LA, Jarrett RB (2009). Deterioration in psychosocial functioning predicts relapse/recurrence after cognitive therapy for depression. Journal of Affective Disorders 112, 139–143.
Weissman MM, Bothwell S (1976). Assessment of social adjustment by patient self-report. Archives of General Psychiatry 33, 1111–1115.
Weissman MM, Markowitz JC, Klerman GL (2000). Comprehensive Guide to Interpersonal Psychotherapy. Basic Books: New York.
Weissman MM, Olfson M, Gameroff MJ, Feder A, Fuentes M (2001). A comparison of three scales for assessing social functioning in primary care. American Journal of Psychiatry 158, 460–466.
Whisman MA (1993). Mediators and moderators of change in cognitive therapy of depression. Psychological Bulletin 114, 248–265.
Wilson G, Fairburn CC, Agras W, Walsh B, Kraemer H (2002). Cognitive-behavioral therapy for bulimia nervosa: time course and mechanisms of change. Journal of Consulting and Clinical Psychology 70, 267–274.
Young J, Beck AT (1980). Cognitive Therapy Scale: Rating Manual. Center for Cognitive Therapy: Philadelphia.